tiprankstipranks
Trending News
More News >

Jude Onyia Insider Profile

4 Followers
Jude Onyia, CSO at Neurocrine, holds 15.17K shares in Neurocrine (Ticker: NBIX), holds ― shares in Voyager Therapeutics (Ticker: VYGR).
tipranks
Jude Onyia

Jude Onyia
Neurocrine (NBIX)
CSO

Not Ranked
Jude Onyia has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
0.00%
A breakdown of Jude Onyia's holdings

Insider Roles

Neurocrine
(NBIX)
CSO
Voyager Therapeutics
(VYGR)
Director
Roles that Jude Onyia holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Jude Onyia

Jude Onyia's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Neurocrine
Aug 07, 2025
CSO
Uninformative Sell
$2.00M
Voyager Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Jude Onyia's performance on stock

Jude Onyia insider profile FAQ

What is the percentage of profitable transactions made by Jude Onyia?
The percentage of profitable transactions made by Jude Onyia is ―.
    What is the average return per transaction made by Jude Onyia?
    The average return per transaction made by Jude Onyia is ―.
      What stocks does Jude Onyia hold?
      Jude Onyia holds: NBIX, VYGR stocks.
        What was Jude Onyia’s latest transaction?
        Jude Onyia latest transaction was an Uninformative Sell of ―.
          What was Jude Onyia's most profitable transaction?
          Jude Onyia’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Jude Onyia's role in Neurocrine?
            Jude Onyia's role in Neurocrine is CSO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.